When the case is uncertain, our AI helps reinforce your call

From a histology slide, DiaDeep delivers objective insights that support your judgment across diagnosis, prognosis, and therapy.
Test itJoin a study

Founded by 40+ pathologists & oncologists, backed by global institutions putting patients first

IHP Group Gustave Roussy Foch CHUM CLB CHU Cean IHP Group Gustave Roussy Foch CHUM CLB CHU Cean
IHP Group Gustave Roussy Foch CHUM CLB CHU Cean IHP Group Gustave Roussy Foch CHUM CLB CHU Cean

Building digital assays to support you in every cancer decision

image

DiaKwant™
Biomarkers quantification

You might start enjoying biomarker scoring
*CE-IVDR pending
Explore biomarkers
image

DiaSurv™
Prognosis prediction

You can know your patient’s risk from day 1
*Open for research collaboration
Explore indications

Bringing clinical evidence for all our solutions

1st

Worldwilde study in melanoma prognosis

Research evidence that survival insights can be derived from histology in early-stage melanoma on 500+ patients cases.
10.000+

Slides analyzed with DiaKwant™

Applied to more than 10,000 slides in day-to-day laboratory use (RUO) in order to demonstrate reliability in real-world settings.
22+

Posters

Presented major oncology and pathology conference across the globe, reinforcing our commitment to scientific excellence and global collaboration.

Highlights made possible by our partners

image of biotech research process for ai biotech company
Publication

Clinical evaluation of an automated pan-organ combined PD-L1 scoring using artificial intelligence on immunostained whole-slide images

Sep 12, 2025

Publication

Jun 1, 2025

Risk score stratification of cutaneous melanomas based on whole slide images using deep learning.
ASCO
Publication

May 28, 2025

Use of artificial intelligence to identify high risk profiles in early stage melanoma patients from pathology slides.
ASCO
Publication

May 28, 2025

Evaluation of AI-assisted PD-L1 CPS scoring in immunostained pan-organ tumor whole-slide images.
ASCO
Read more

Standing beside those who care for patients

care-img

Why we exist?

We know every decision matters because we have lived it. That’s why we built DiaDeep.
Built by pathologists, oncologists, and AI scientists who understand the stakes of every decision.
care-img

How we work?

You share your toughest challenges. We build solutions together to bring them to patients.
care-img

Our promise

We don’t overpromise! we deliver useful solutions that work, validated with 60+ pathologists and clinicians, and backed by clinical evidence.
Learn about us

Have fun with PD-L1:
play, learn and master the CPS!

Train your PD-L1 CPS with real cases, track your progress and see how you rank.
Our first users call it ‘addictive and frustrating’!
Join the challenge
join-img
mobile

Now, you know who weare.
Let’s take the next step together!

image of dna visualization on a screen (for an ai biotech company)

Whether you want to test our DiaKwant™ AI on your slides, take part in a study for DiaSurv™, we’d love to hear from you.

Test itReach out

Every patient matters, every decision counts!